19
Aug

Back in January, the prestigious Sanford-Burnham Medical Research Institute amended its ethos, promising to more closely marry its work to therapeutic development and become a partner of choice for drugmakers. Now, the 38-year-old organization has chosen the leader to get it there, convincing GlaxoSmithKline’s Perry Nisen to take the reins as its new CEO.

…read more

Source: Sanford-Burnham poaches a GSK exec to bridge academia and Big Pharma

    

0 No comments